Dabur India Limited
Established in 1884 by Dr. SK Burman, Dabur India Limited is among the top four FMCG companies in India. It has business interests in healthcare, personal care and food products. Over the years, Dabur India Limited has focused on manufacturing and se...
Key Metrics
EPS
10.40
Current ratio
1.45
Debt/Equity
0.21
Debt/EBITDA
0.75
Interest coverage ratio
19.99
Operating Cashflow to total debt
0.69
Financials
Pros & Cons
Exclusive on TAP Bonds
Here's what we like about this company and potential risks we have identified.
Pros
Healthy operating and financial performance
Ownership of strong brands helped establish strong market position in domestic FMCG space
Strong financial position characterised by negative net debt and superior liquidity position
Company has been maintaining a healthy dividend payout of 53.2%
Liquidity position: Superior
Cons
Intense competition in the industry
Stock is trading at 9.24 times its book value
The company has delivered a poor sales growth of 7.81% over past five years.
Disclaimer: Tap Bonds gathers data directly from the respective OBPP websites but does not guarantee its accuracy. We do not offer investment advice or endorse the purchase of any securities mentioned, nor do we warrant the reliability of the information collected.
About Dabur India Limited bond.
This comprehensive profile covers key factual information about DABUR INDIA LIMITED. Established in 1884 by Dr. SK Burman, Dabur India Limited is among the top four FMCG companies in India. It has business interests in healthcare, personal care and food products. Over the years, Dabur India Limited has focused on manufacturing and selling ayurvedic products targeted at the mass consumer segment. A number of personal care products, ayurvedic tonics and oral care products that Dabur India Limited has launched over the years are leading brands in their respective segments. Dabur India Limited offers products in over 100 countries across the globe, covering health and personal care segments across the herbal and natural space. Dabur's FMCG portfolio includes eight power brands—Dabur Amla, Dabur Red Paste, Dabur Chyawanprash, Dabur Honey, Dabur Honitus, Dabur PudinHara, Dabur Lal Tail and Dabur Real. The company offers over 400 products across 21 categories and over 1,000 Stock Keeping Units (SKUs). It has manufacturing facilities at 22 locations—with 14 in India, and one each in the UAE, Sri Lanka, South Africa, Nepal, Egypt, Bangladesh, Turkey and Nigeria. Dabur India Limited has organised its sales force according to zones for better penetration. Over the years, it has built a strong distribution network of 7.7 million retail outlets across India (as of March 2023). EPS in Mar-2024 was 10.40. Current ratio in Mar-2024 was 1.45. Debt/Equity in Mar-2024 was 0.21. Debt/EBITDA in Mar-2024 was 0.75. Interest coverage ratio in Mar-2024 was 19.99. Operating Cashflow to total debt in Mar-2024 was 0.69. Total revenue for Mar-2025 was ₹13086.13. Net income for Mar-2025 stood at ₹2857.73. Total assets as of Mar-2024 were ₹15,116.36. Operating cash flow for Mar-2024 was ₹2,013.47. The company’s borrowing relationships include Standard Chartered Bank (₹N/A Cr), HDFC Bank Limited (₹N/A Cr), Bank of America (₹N/A Cr), Sumitomo Mitsui Banking Corporation (₹N/A Cr), Axis Bank Limited (₹N/A Cr), RBL Bank Limited (₹N/A Cr), YES Bank Limited (₹N/A Cr), IDBI Bank Limited (₹N/A Cr), ICICI Bank Limited (₹N/A Cr), Citibank N.A. (₹N/A Cr), Not Applicable (₹N/A Cr), RBL Bank Limited (₹N/A Cr), YES Bank Limited (₹N/A Cr), ICICI Bank Limited (₹N/A Cr). Peers and comparison entities consist of DABUR INDIA LIMITED, Godrej Consumer Products Limited, Marico Limited, Colgate-Palmolive (India) Limited. As of Dec 2024, promoters hold N/A% while others hold N/A% of equity. Key strengths include: Healthy operating and financial performance; Ownership of strong brands helped establish strong market position in domestic FMCG space; Strong financial position characterised by negative net debt and superior liquidity position ; Company has been maintaining a healthy dividend payout of 53.2%; Liquidity position: Superior. Key risks include: Intense competition in the industry ; Stock is trading at 9.24 times its book value; The company has delivered a poor sales growth of 7.81% over past five years.. Leadership team details include A K Jain (Executive Vice President & Company Secretary), Aditya Burman (Director), Ajay Dua (Independent Director), Ajit Mohan Sharan (Independent Director), Amit Burman (Director), Ankush Jain (Chief Financial Officer), Falguni Sanjay Nayar (Independent Director), Mohit Burman (Chairman), Mohit Malhotra (WholeTime Director & CEO), Mukesh Butani (Lead Independent Director), P D Narang (Whole Time Director), P N Vijay (Independent Director), R C Bhargava (Independent Director), Rajiv Mehrishi (Independent Director), Romesh Sobti (Independent Director), S Narayan (Independent Director), Saket Burman (Vice Chairman), Satyavati Berera (Independent Director). This detailed corporate overview is structured to provide a thorough understanding of all available data points, enhance search visibility, and support investor analysis.